Revelation Biosciences Inc expected to post a loss of 83 cents a share - Earnings Preview
Revelation Biosciences Inc <REVB.OQ> expected to post a loss of 83 cents a share - Earnings Preview
Revelation Biosciences Inc REVB.OQ REVB.O is expected to show no change in quarterly revenue when it reports results on August 6 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Revelation Biosciences Inc is for a loss of 83 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Revelation Biosciences Inc is $53.00, about 5,096.1% above its last closing price of $1.02
This summary was machine generated August 4 at 14:07 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)